| 发明名称 |
Medicinal product for the treatment of diabetes |
| 摘要 |
The use of physiologically acceptable enzyme mixtures with lipolytic, proteolytic and amylolytic activity in the manufacture of medicaments for the treatment of type I primary diabetes mellitus in larger mammals or humans.
|
| 申请公布号 |
NZ514826(A) |
申请公布日期 |
2003.08.29 |
| 申请号 |
NZ20000514826 |
申请日期 |
2000.03.15 |
| 申请人 |
SOLVAY PHARMACEUTICALS GMBH |
发明人 |
SANDER-STRUCKMEIER, SUNTJE;STEINBORN, CLAUS;RUDMANN, MARTIN;SCHWANITZ, DIETER;HENNIGES, FRIEDERIKE |
| 分类号 |
C12N9/14;A61K38/43;A61K38/46;A61K38/47;A61K38/54;A61P3/10;(IPC1-7):A61K38/46 |
主分类号 |
C12N9/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
